QV Bioelectronics

QV Bioelectronics is a developer of electrotherapy devices for brain tumors. The company's technology targets residual cancer cells, and the use of graphene helps optimize the performance and practical application of the devices, enabling surgeons to significantly improve clinical outcomes and patients' quality of life.